Showing results (11-20 of 534) with videos related to
Sort By:
Pageof 54
The Journal of Antimicrobial Chemotherapy|May 1, 1997
Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus sppJ D Williams, J P Maskell, A C Whiley, et al.Infection|May 1, 1989
In-vitro activity of lomefloxacin (SC-47111) and other quinolonesZ M Sun, J P Maskell, S C Sehgal, et al.The Journal of Antimicrobial Chemotherapy|February 1, 1986
Behaviour of TEM-1 beta-lactamase as a resistance mechanism to ampicillin, mezlocillin and azlocillin in Escherichia coliD M Livermore, F Moosdeen, M A Lindridge, et al.The Journal of Antimicrobial Chemotherapy|April 1, 1996
Comparative in-vitro activity of CP-99219, a new quinolone, against respiratory pathogensA M Sefton, J P Maskell, A C Seymour, et al.The Journal of Antimicrobial Chemotherapy|June 1, 1997
The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteriaA M Sefton, J P Maskell, A M Rafay, et al.Infection|January 1, 1988
Comparative in-vitro activity of erythromycin, vancomycin and pristinamycinJ P Maskell, A M Sefton, J Yong, et al.Journal of Medical Microbiology|June 1, 1984
Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosaR J Williams, D M Livermore, M A Lindridge, et al.The Journal of Antimicrobial Chemotherapy|July 1, 1984
National survey of antibiotic resistance in Pseudomonas aeruginosaR J Williams, M A Lindridge, A A Said, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Comparative in vitro activity of A-56268A M Sefton, J P Maskell, F J Yong, et al.Reviews of Infectious Diseases|July 1, 1988
Permeation of beta-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other gram-negative bacteriaD M LivermorePageof 54